Rationale: There is uncertainty about the effects of treating obstructive sleep apnea on
glycemic control in patients with type 2 diabetes. Objectives: To determine whether treatment …

Rationale: Obstructive sleep apnea (OSA) is a risk factor for type 2 diabetes that adversely
impacts glycemic control. However, there is little evidence about the effect of continuous …

Results: The combined standard (STD) paired difference in mean change in the levels of
glycated haemoglobin (HbA 1c) was–0.073%(standard error (SE): 0.126), indicating that …

Methods Adults with T2DM and OSA were recruited at the University of Chicago between
November 2009 and September 2014. Subjects were eligible if they were newly diagnosed …

Rationale: Although obstructive sleep apnea (OSA) is associated with impaired glucose
tolerance and diabetes, it remains unclear whether OSA treatment with continuous positive …

Rationale: Obstructive sleep apnea (OSA), a treatable sleep disorder that is associated with
alterations in glucose metabolism in individuals without diabetes, is a highly prevalent …

Context: Few prospective intervention studies have examined the effect of continuous
positive airway pressure (CPAP) therapy on cardiovascular disease (CVD) risk factors in …

Background: Obstructive sleep apnea (OSA), a highly prevalent condition, is independently
associated with increased risks of developing type 2 diabetes mellitus (T2D) and metabolic …

OBJECTIVE Despite evidence of a relationship among obstructive sleep apnea (OSA),
metabolic dysregulation, and diabetes, it is uncertain whether OSA treatment can improve …

Obstructive sleep apnea (OSA) is independently associated with glucose intolerance and
insulin resistance, and recent studies have shown that continuous positive airway pressure …